Circulation
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Low cardiac output syndrome (LCOS), affecting up to 25% of neonates and young children after cardiac surgery, contributes to postoperative morbidity and mortality. This study evaluated the efficacy and safety of prophylactic milrinone in pediatric patients at high risk for developing LCOS. ⋯ The use of high-dose milrinone after pediatric congenital heart surgery reduces the risk of LCOS.